🧪
hypothesis

STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine Memory

Hypothesis

STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine Memory

STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine Memory.
🧬 IL-6/STAT3/BRD4 axis; target: microglial STAT3 phosphorylation🩺 immunomics🎯 Composite 35%💱 $0.45▲34.8%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 4 support 5 oppose
⚠ Missing Evidence⚠ Thin Description Senate Quality Gates →
Mechanistic 0.30 (15%) Evidence 0.25 (15%) Novelty 0.65 (12%) Feasibility 0.30 (12%) Impact 0.35 (12%) Druggability 0.35 (10%) Safety 0.30 (8%) Competition 0.75 (6%) Data Avail. 0.25 (5%) Reproducible 0.25 (5%) KG Connect 0.50 (8%) 0.347 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite35%

🧪 Overview

STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine Memory

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Peripheral Cytokine<br/>IL-6 Elevation"]
    B["Monocyte STAT3<br/>Phosphorylation Activation"]
    C["Epigenetic Priming<br/>BRD4 Reader Complex"]
    D["Pro-inflammatory Memory<br/>Training"]
    E["Brain Border Macrophage<br/>Reprogramming"]
    F["Neuroinflammation<br/>Amplification"]
    G["IL-6/STAT3/BRD4 Axis<br/>as Immunomodulation Target"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    G -.->|"modulates"| B
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7

⚖️ Evidence

⚖️ Evidence Matrix4 supports5 contradicts
Supports
IL-6 trans-signaling activates STAT3 in primary microglia
PMID:15936006
Supports
STAT3 inhibition reduces pro-inflammatory gene expression in 5xFAD mice
PMID:31255076
Supports
BRD4 binds super-enhancers at inflammatory genes in LPS-primed macrophages
PMID:24335479
Supports
CSF IL-6 predicts conversion from MCI to AD
PMID:25533297
Contradicts
CRITICAL MECHANISTIC ERROR: HDAC6 is cytoplasmic deacetylase; does not regulate transcription or chromatin - cited as epigenetic mechanism incorrectly
PMID:28539446
Contradicts
Trained immunity concept (long-term epigenetic reprogramming) well-established in monocytes/macrophages but applicability to brain microglia remains THEORETICAL
PMID:trained_immunity
Contradicts
IL-6 can activate neuroprotective pathways via STAT3 in neurons; global inhibition could remove beneficial effects
PMID:12529404
Contradicts
WP1066 (proposed STAT3 inhibitor) has significant off-target effects and toxicity limiting clinical development
PMID:WP1066_toxicity
Contradicts
BRD4 super-enhancers demonstrated in macrophages; whether mechanism operates in embryologically distinct microglia is unproven
PMID:24335479
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — IL-6

No curated PDB or AlphaFold mapping for IL-6 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for IL-6/STAT3/BRD4 axis; target: microglial STAT3 phosphorylation from GTEx v10.

Spinal cord cervical c-132.3 Cerebellum31.1 Cerebellar Hemisphere29.6 Hypothalamus23.8 Substantia nigra22.0 Cortex20.2 Caudate basal ganglia18.7 Frontal Cortex BA918.7 Nucleus accumbens basal ganglia17.5 Amygdala17.1 Anterior cingulate cortex BA2416.6 Putamen basal ganglia15.0 Hippocampus14.4median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for IL-6 →

No DepMap CRISPR Chronos data found for IL-6.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Rising
7d Momentum
▲ 1.8%
Volatility
Medium
0.0299
Events (7d)
3
Price History
▲34.8%

💾 Resource Usage

LLM Tokens
36,998
$0.1110
Total Cost
$0.1110

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF BRD4 inhibitor JQ1 (50 mg/kg, intraperitoneally) is administered concurrently during peripheral IL-6 priming (100 ng/kg for 5 days), THEN the magnitude of microglial STAT3 phosphorylation elevationConcurrent BRD4 inhibition will completely abolish the peripheral IL-6-induced priming of microglial STAT3 phosphorylation, reducing p-STAT3 to baseline levels — no observation —pending0.55
IF adult C57BL/6 mice receive peripheral IL-6 administration (100 ng/kg, intraperitoneally) for 5 consecutive days, THEN isolated brain microglia will show significantly elevated STAT3 phosphorylationMicroglial p-STAT3 levels will remain elevated (≥2-fold above baseline) at 30 days post-IL-6 exposure, demonstrating persistent 'cytokine memory' effect.— no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF adult C57BL/6 mice receive peripheral IL-6 administration (100 ng/kg, intraperitoneally) for 5 consecutive days, THEN isolated brain microglia will show significantly elevated STAT3 phosphorylation levels (p<0.05, ≥2-fold increase) compared to vehicle-treated controls at 30 days post-exposure.
Predicted outcome: Microglial p-STAT3 levels will remain elevated (≥2-fold above baseline) at 30 days post-IL-6 exposure, demonstrating persistent 'cytokine memory' effe
Falsification: Microglial STAT3 phosphorylation at 30 days post-exposure shows no significant difference from vehicle controls (<1.2-fold change, p≥0.05), indicating no lasting priming effect.
pendingconf 55%
IF BRD4 inhibitor JQ1 (50 mg/kg, intraperitoneally) is administered concurrently during peripheral IL-6 priming (100 ng/kg for 5 days), THEN the magnitude of microglial STAT3 phosphorylation elevation at 30 days will be indistinguishable from vehicle-only controls (fold change <1.2, p≥0.05), whereas
Predicted outcome: Concurrent BRD4 inhibition will completely abolish the peripheral IL-6-induced priming of microglial STAT3 phosphorylation, reducing p-STAT3 to baseli
Falsification: IL-6 + JQ1 co-treatment still produces ≥1.5-fold elevation in microglial STAT3 phosphorylation at 30 days, demonstrating the mechanism is independent of BRD4-dependent epigenetic priming.
View on SciDEX ↗